Brewin Dolphin LTD Inovio Pharmaceuticals, Inc. Transaction History

Brewin Dolphin LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2023	SELL	$7.16 - $9.69 $11,814 - $15,988	-1,650 Reduced 55.71%	1,312 $9.39 Million
Q1 2021 Nov 09, 2023	BUY	$8.81 - $16.96 $14,536 - $27,984	1,650 Added 125.76%	2,962 $27.5 Million
Q4 2020 Nov 09, 2023	SELL	$8.5 - $12.85 $1,581 - $2,390	-186 Reduced 12.42%	1,312 $11.6 Million
Q3 2020 Nov 09, 2023	SELL	$9.57 - $27.05 $45,916 - $129,785	-4,798 Reduced 76.21%	1,498 $17.4 Million
Q2 2020 Nov 09, 2023	BUY	$7.14 - $31.69 $34,157 - $151,604	4,784 Added 316.4%	6,296 $170 Million
Q1 2020 Nov 09, 2023	BUY	$2.98 - $14.09 $3,465 - $16,386	1,163 Added 333.24%	1,512 $11.2 Million
Q4 2019 Nov 09, 2023	SELL	$1.97 - $3.72 $9,850 - $18,600	-5,000 Reduced 93.48%	349 $1.15 Million
Q3 2019 Nov 09, 2023	SELL	$2.05 - $3.02 $25,571 - $37,671	-12,474 Reduced 69.99%	5,349 $11 Million
Q1 2019 Nov 09, 2023	SELL	$3.34 - $5.1 $137,942 - $210,629	-41,300 Reduced 69.85%	17,823 $66.5 Million
Q3 2017 Nov 09, 2023	BUY	$5.36 - $6.37 $316,899 - $376,613	59,123	59,123 $375 Million

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $489M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

Stay updated on Brewin Dolphin LTD with notifications on news.